article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

“There’s everything from people being dosed without their consent, to people being encouraged to sleep with practitioners in exchange for services, to people being pressured to participate in group contexts, and so-called rituals that they otherwise wouldn’t have engaged in.” ” Underground researcher.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

It became illegal in the US in 2009. Stage three lasts up to 72 hours after ingestion, and is characterized by mild stimulation, heightened awareness and disrupted sleep. Just like in the cannabis space, we’re seeing advocacy, legalization, and competition among industries to provide these medicines.

History 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. But the research wasn’t enough. But the research wasn’t enough.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Community-driven regulation was a frequent frame across the study period, acknowledging the role of grassroots activism in the legislation process and recognising medicinal cannabis advocacy as part of a social movement. Full size image.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund.